Chen Zai-zhong, Yang Ren-jie, Liu Peng-cheng
Department of Interventional Therapy, School of Oncology, Peking University, Beijing 100036, China.
Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):859-62.
To evaluate the safety and feasibility of two-step portal vein embolization in treatment of hepatic fibrosis.
Twenty rabbit underwent intraperitoneal injection of carbon tetrachloride to establish models of hepatic fibrosis, and then were randomly divided into 2 equal groups: one-step group in which ileocolic vein was exposed, portal angiography was conducted, a catheter was inserted into the upper end of the main trunk of portal vein beyond the branches of right lower lobe of liver, a mixture of absolute ethanol- lipiodol was infused into the portal vein branches supplying 70% - 90% of the liver via a catheter and then a coil was put at the proximal side of hepatic portal, and two-step group in which the portal vein branches were embolized by using a mixture of absolute ethanol-lipiodol first at the first step and then by using polyvinyl alcohol particles 4 weeks later during the second operation. Follow-up was conducted for 7 weeks. The serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), total bilirubin, and albumin were examined before and 4, 7, and 14 days after the portal vein embolization. Computed tomography was performed before and after the embolization to observe the changes of the liver volume and compare the volumes of the embolized and non-embolized lever segments. After the rabbits were sacrificed, pathological examination of the liver was conducted.
Successful portal vein embolization was achieved in both groups. One rabbit of the one-step group died during the operation and 2 rabbits of the 2-step group died of bleeding or infection. The levels of ALT and AST increased after the procedure, peaked at the fourth day, and returned to normal one week later. Pathology showed that after the embolization the right lower lobe of liver was hypertrophic to a certain degree and the other part of the liver became atrophic. The hypertrophy percentage of non-embolized liver was higher by 7.0 +/- 1.3% in the one-step group and by 15.4% +/- 3.0% in the two-step group (both P < 0.05).
A more great degree of hypertrophy in the non-embolized liver segment can be achieved by two-step portal vein embolization.
评估两步法门静脉栓塞治疗肝纤维化的安全性和可行性。
20只家兔经腹腔注射四氯化碳建立肝纤维化模型,然后随机分为两组,每组10只:一步组,暴露回结肠静脉,行门静脉造影,将导管插入门静脉主干上端、肝右下叶分支以上部位,经导管向供应肝脏70% - 90%的门静脉分支注入无水乙醇-碘油混合液,然后在肝门近端放置弹簧圈;两步组,第一步先用无水乙醇-碘油混合液栓塞门静脉分支,4周后第二步手术时再用聚乙烯醇颗粒栓塞。随访7周。在门静脉栓塞前及栓塞后4天、7天和14天检测血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆红素和白蛋白水平。栓塞前后行计算机断层扫描,观察肝脏体积变化,比较栓塞和未栓塞肝段的体积。家兔处死后,对肝脏进行病理检查。
两组均成功实现门静脉栓塞。一步组1只家兔术中死亡,两步组2只家兔死于出血或感染。术后ALT和AST水平升高,第4天达到峰值,1周后恢复正常。病理显示,栓塞后肝右下叶有一定程度的肥大,肝脏其他部分萎缩。一步组未栓塞肝脏的肥大百分比高于两步组,分别为(7.0±1.